Illumina, Inc.

Main EU Legislative Proposals: Illumina follows policy and legislative developments related to genomics, agri-genomics, public health, animal health, agriculture, forensics, biotechnology, data protection, science, and research policies. In particular, Illumina follows the discussions on the proposal for a EU Health Data Space (EHDS) and developments relating to the Regulations on medical devices (MDR) and In-vitro diagnostics (IVDR). It also engages in policy and regulatory initiatives relating to research and innovation in the EU (Horizon Europe), including more generally developments relating to EU research programs, with a focus on genomics research. Additionally, Illumina focuses on policy developments related to the Beating Cancer Plan, the 1+Million Genomes Initiative, the EU Action on Antimicrobial Resistance (AMR), the EU Covid-19 policy response, the implementation of the NextGenerationEU Plan, and the EU orphan medicines legislation. Moreover, an emphasis is also given to monitoring the review in scope and responsibilities of key institutional stakeholders such as the European Medicine Agency (EMA), the European Center for Disease Control (ECDC) and the European Health Emergency preparedness and Response Authority (HERA).

Inter-institutional or Unofficial Groupings: N/A